Subscribe To
Corvus pharmaceuticals announces publication of preclinical data demonstrating potential of itk inhibition with soquelitinib as a novel approach to t cell-mediated inflammatory and immune diseases
Data demonstrated soquelitinib was active in six inflammatory/immune disease models and provides ration...
November 1, 2023, 11:31 pm
Zyversa therapeutics announces publication in molecular neurobiology reinforcing data demonstrating that inflammasome asc inhibitor ic 100 attenuates the inflammatory response causing neuronal damage
Molecular Neurobiology publication demonstrated that NLRP3 inflammasomes have an important role in the pathogenesis of multiple sclerosis (“MS”) b...
November 1, 2023, 12:07 pm
Cardiol therapeutics reaches new milestone in phase ii study for recurrent pericarditis
Cardiol Therapeutics (TSX:CRDL, NASDAQ:CRDL) announced it has successfully enrolled over 50% of the targeted number of patients for its Phase II open-...
November 1, 2023, 8:41 am
Amgen gets fda approval for its inflammatory diseases treatment wezlana
Amgen AMGN, -2.85% has received approval from the U.S. Food and Drug Administration for Wezlana, its treatment for multiple ...
October 31, 2023, 7:22 pm
U.s. fda approves amgen's biosimilar vesrion of j&j's stelara
The U.S. Food and Drug Administration on Tuesday approved Amgen's biosimilar version of Johnson & Johnson's blockbuster psoriasis treatment Stelara fo...
October 31, 2023, 6:32 pm
Omega therapeutics presents new preclinical data demonstrating pre-transcriptional modulation of multiple cxcl genes by a single epigenomic controller
Coordinated modulation of epigenetic profile of CXCL1-8 genes with corresponding downregulation of gene expression and protein levels, and inhibition ...
October 31, 2023, 11:00 am
Eli lilly bowel disease drug approved in us
Eli Lilly and Co (NYSE:LLY) has announced that its Omvoh drug has been approved by the US Food and Drug Administration to treat types of ...
October 27, 2023, 3:52 am
Altimmune to present new data on the anti-inflammatory and anti-fibrotic properties of pemvidutide in a late-breaking presentation at the liver meeting® 2023
GAITHERSBURG, Md., Oct. 25, 2023 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that n...
October 25, 2023, 7:30 am
Why is lianbio (lian) stock up 130% today?
Shares of LianBio (NASDAQ: LIAN ) — which focuses on “developing and commercializing medicines for cardiovascular, oncology, opthalmology, and
October 24, 2023, 1:48 pm
Roche enters into a definitive agreement to acquire telavant including rights to novel tl1a directed antibody (rvt-3101) for the treatment of inflammatory bowel disease from roivant
Roche will gain the rights to develop, manufacture and commercialize RVT-3101 in the US and Japan for the treatment of ...
October 23, 2023, 5:00 am
Roche splashes us$7.1 billion on new irritable bowel drug
Roche has agreed to pay US$7.1 billion for an early-stage inflammatory bowel disease treatment develop...
October 23, 2023, 4:44 am
Gri bio announces partnership with the respiratory translational research collaboration to advance leading nkt regulation technology targeting earlier in the inflammatory cascade to modulate disease p
UK consortia brings together internationally recognized investigators in the UK’s leading centers of excellence to carry out experimental and early ...
October 17, 2023, 12:35 pm
J&j raises annual profit forecast on anti-inflammatory drug demand
Johnson & Johnson on Tuesday raised its 2023 profit forecast, helped by resilient demand for its anti-inflamma...
October 17, 2023, 6:22 am
U.s. fda approves pfizer's inflammatory bowel disease drug
Pfizer said on Friday that theU.S. Food and Drug Administration has approved its drug to treat adults with moderate-to-severe ...
October 13, 2023, 9:09 am
Alpine immune sciences to present initial clinical data on povetacicept in autoimmune glomerulonephritis in a late breaker poster session at american society of nephrology kidney week 2023
SEATTLE--(BUSINESS WIRE)--Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunotherapy company focused on developing innovative...
October 13, 2023, 9:05 am
Tiziana life sciences reveals positive pet scan results with foralumab to treat ms patients
Tiziana Life Sciences Ltd (NASDAQ:TLSA) announced that a reduction in activated microglia, as seen in six-month Positron Emission Tomography (PET) s...
October 13, 2023, 8:34 am
Cardiol therapeutics says study results show positive effects of subcutaneously administered cannabidiol
Cardiol Therapeutics (TSX:CRDL, NASDAQ:CRDL) has reported positive study results showing that cannabidiol, the active pharmaceutical ingredient in the...
October 10, 2023, 8:15 am
Gri bio announces publication of comprehensive invariant nkt (inkt) cell review in frontiers in immunology demonstrating a key role of type 1 inkt cells in modulating various fibrotic conditions
In several murine models of chronic inflammation and fibrosis, as well as in humans, it has been shown that iNKT cells are selectively activated in th...
October 5, 2023, 12:45 pm
Sanofi (sny) signs deal to co-develop teva's ibd candidate
Sanofi (SNY) and Teva enter into a collaboration deal to co-develop and co-commercialize the latter's inflamma...
October 4, 2023, 12:01 pm
Teva partnership with sanofi ‘will pay dividends,' analyst says
Teva Pharmaceutical Industries Ltd.'s TEVA, -4.10% new collaboration with Sanofi SNY, on an inflammatory...
October 4, 2023, 8:50 am
